These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9616538)

  • 1. A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease.
    Cazzola M; Matera MG; Di Perna F; Calderaro F; Califano C; Vinciguerra A
    Respir Med; 1998 Feb; 92(2):354-7. PubMed ID: 9616538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
    Cazzola M; Di Perna F; Noschese P; Vinciguerra A; Calderaro F; Girbino G; Matera MG
    Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.
    Cazzola M; Di Perna F; Centanni S; Califano C; Donner CF; D'Amato M; D'Amato G
    Thorax; 1999 Dec; 54(12):1083-6. PubMed ID: 10567627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease.
    Matera MG; Cazzola M; Vinciguerra A; Di Perna F; Calderaro F; Caputi M; Rossi F
    Pulm Pharmacol; 1995 Dec; 8(6):267-71. PubMed ID: 8819181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug.
    Frith PA; Jenner B; Dangerfield R; Atkinson J; Drennan C
    Chest; 1986 Feb; 89(2):249-53. PubMed ID: 3510822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study.
    Cazzola M; Matera MG; Santangelo G; Vinciguerra A; Rossi F; D'Amato G
    Respir Med; 1995 May; 89(5):357-62. PubMed ID: 7638371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD.
    Cazzola M; Matera MG; Di Perna E; Califano C; D'Amato M; Mazzarella G
    Respir Med; 1999 Dec; 93(12):909-11. PubMed ID: 10653054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease.
    Cazzola M; Santangelo G; Piccolo A; Salzillo A; Matera MG; D'Amato G; Rossi F
    Pulm Pharmacol; 1994 Apr; 7(2):103-7. PubMed ID: 7915921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The new anticholinergic bronchospasmolytic oxitropium bromide. Is long lasting protective effect through the night].
    Kneubühler HR; Kyd K; Benoit RC; Scherrer M
    Schweiz Med Wochenschr; 1980 May; 110(21):812-6. PubMed ID: 7394499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to bronchodilating effects of salmeterol in COPD.
    Donohue JF; Menjoge S; Kesten S
    Respir Med; 2003 Sep; 97(9):1014-20. PubMed ID: 14509555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive pulmonary disease.
    Patakas D; Andreadis D; Mavrofridis E; Argyropoulou P
    Respir Med; 1998 Sep; 92(9):1116-21. PubMed ID: 9926165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the bronchodilating effects of oxitropium bromide and fenoterol in patients with chronic obstructive pulmonary disease.
    Koyama H; Nishimura K; Ikeda A; Izumi T
    Chest; 1993 Dec; 104(6):1743-7. PubMed ID: 8252955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled oxitropium bromide is currently used as the first-line therapy of patients with chronic pulmonary disease in Japan.
    Teramoto S; Ouchi Y
    Eur Respir J; 1999 Feb; 13(2):473-5. PubMed ID: 10065703
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the bronchodilator activities of oxitropium bromide, fenoterol, and their combination in patients with chronic obstructive pulmonary disease and bronchial asthma.
    Nishi K; Fujimura M; Myou S; Ooka T; Sakamoto S; Saitou M; Kasahara K; Matsuda T
    Clin Auton Res; 1993 Feb; 3(1):41-4. PubMed ID: 8477180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPD.
    Cazzola M; Di Perna F; Califano C; Vinciguerra A; D'Amato M
    Pulm Pharmacol Ther; 1999; 12(4):267-71. PubMed ID: 10501652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.